OCU-VET Fusion Base™ is a modular, multimodal ophthalmic platform that unifies advanced diagnostic and therapeutic technologies into a single, integrated system for veterinary eye care. The platform combines ultraviolet antimicrobial therapy (UV-C), corneal cross-linking for biomechanical corneal stabilization, and colorimetric pupillary light reflex (PLR) assessment powered by Melan 100 technology. Its modular architecture allows seamless integration of each modality within a compact clinical footprint, supporting both precision diagnostics and advanced treatment from one central platform. Engineered for efficiency, accuracy, and future scalability, OCU-VET Fusion Base™ enables clinicians to elevate ophthalmic care while optimizing clinical workflow.
The Science Behind UV-C Treatment (Mechanism of Action)
Activity against prokaryotic cells (bacteria, fungi, protozoa, viruses):
- UV-C causes an alteration at the spatial structure of the DNA resulting in 2 photoproducts:
- Pyrimidine-Pyrimidone (6-4 PP)
- Cyclobutane Pyrimidine Dimers (CPD)
- These products are lethal, leading to cell death or impair the replication process
- Additionally it produces free O2 radicals that cause destruction of DNA
Note: Eukaryotic cells have repair mechanisms for these photoproducts: 6-4 PP is repaired with high efficiency, while CPD will take longer time
Scientific Papers (References)
1. Turicea B, Sahoo DK, Allbaugh RA, Stinman CC, Kubai MA. Novel treatment of infectious keratitis in canine corneas using ultraviolet C (UV-C) light. Vet Ophthalmol. 2024;00:1-15. doi:10.1111/vop.13265
2. Marasini S. Exploring the Potential of UVC in Treating Superficial Corneal Infections (PhD Thesis). The University of Auckland; 2019
3. Hoerdemann M, Sahoo DK, Allbaugh RA, Kubai MA. Ultraviolet C (UV-C) Light Therapy for Equine Ulcerative Keratomycosis-An In Vitro Study. Vet Ophthalmol. Mar 5 2025; doi:10.1111/vop.70012
4. Marasini S, Dean SJ, Swift S, et al. Preclinical confirmation of UVC efficacy in treating infectious keratitis. Ocul Surf. 2022;25:76-86. doi:10.1016/j.jtos.2022.05.004
5. Dean SJ, Petty A, Swift S, et al. Efficacy and safety assessment of a novel ultraviolet C device for treating corneal bacterial infections. Clin Exp Ophthalmol. 2011;39(2):156-163. doi:10.1111/j.1442-9071.2010.02471
6. Marasini S, Mugisho OO, Swift S, et al. Effect of therapeutic UVC on corneal DNA. Safety assessment for potential keratitis treatment. Ocul Surf. 2021;20:130-138. doi:10.1016/j.jtos.2021.02.005
7. Kaidzu S, Sugihara K, Sasaki M, Nishiaki A, Igarashi T, Tanito M. Evaluation of acute corneal damage induced by 222-nm and 254-nm ultraviolet light in Sprague-Dawley rats. Free Radic Res. 2019;6(53):611-617. doi:10.1080/10715762.2019.1603378